X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cremophor-free (262) 262
humans (174) 174
index medicus (172) 172
paclitaxel (128) 128
oncology (105) 105
animals (99) 99
pharmacology & pharmacy (99) 99
albumin-bound paclitaxel (98) 98
female (95) 95
cancer (82) 82
nanoparticles (80) 80
phase-ii trial (74) 74
paclitaxel - administration & dosage (72) 72
genexol-pm (71) 71
chemotherapy (70) 70
drug delivery systems (67) 67
cell line, tumor (61) 61
micelles (61) 61
nab-paclitaxel (58) 58
mice (57) 57
drugs (50) 50
male (50) 50
antineoplastic agents, phytogenic - administration & dosage (47) 47
paclitaxel - therapeutic use (45) 45
drug-delivery (44) 44
phase-i (44) 44
neoplasms - drug therapy (43) 43
abi-007 (42) 42
pharmacokinetics (42) 42
vehicles (41) 41
chemistry, multidisciplinary (40) 40
antitumor-activity (39) 39
middle aged (38) 38
paclitaxel - chemistry (38) 38
aged (37) 37
nanoparticles - chemistry (37) 37
paclitaxel - pharmacokinetics (37) 37
breast-cancer (36) 36
breast cancer (35) 35
breast neoplasms - drug therapy (35) 35
formulation (35) 35
antineoplastic agents, phytogenic - pharmacokinetics (34) 34
docetaxel (34) 34
polymeric micelles (34) 34
treatment outcome (34) 34
adult (33) 33
tumors (33) 33
phase-iii trial (31) 31
antineoplastic agents, phytogenic - therapeutic use (30) 30
nanoparticle formulation (30) 30
paclitaxel - pharmacology (30) 30
taxol (29) 29
antineoplastic agents - administration & dosage (28) 28
paclitaxel - adverse effects (28) 28
albumins - administration & dosage (27) 27
care and treatment (27) 27
drug delivery (27) 27
in-vitro (27) 27
mice, nude (27) 27
nanoscience & nanotechnology (27) 27
albumins - therapeutic use (26) 26
antimitotic agents (26) 26
antineoplastic agents (26) 26
drug carriers - chemistry (26) 26
in-vivo (26) 26
polymeric micelle formulation (26) 26
cell survival - drug effects (25) 25
antineoplastic combined chemotherapy protocols - therapeutic use (24) 24
drug delivery systems - methods (24) 24
particle size (24) 24
polyethylene glycols - chemistry (24) 24
solid tumors (24) 24
antineoplastic agents - therapeutic use (23) 23
nanotechnology (23) 23
pharmacology/toxicology (23) 23
analysis (22) 22
antineoplastic agents, phytogenic - chemistry (22) 22
antineoplastic agents, phytogenic - pharmacology (22) 22
cell lung-cancer (22) 22
metastatic breast-cancer (22) 22
polymers (22) 22
trial (22) 22
article (21) 21
nanomedicine (21) 21
xenograft model antitumor assays (21) 21
1st-line therapy (20) 20
albumin (20) 20
delivery (20) 20
solvent-based paclitaxel (20) 20
antineoplastic agents - chemistry (19) 19
chemistry, pharmaceutical (19) 19
solubility (19) 19
breast neoplasms - pathology (18) 18
hematology, oncology and palliative medicine (18) 18
materials science, multidisciplinary (18) 18
mice, inbred balb c (18) 18
nanoparticle (18) 18
polymers - chemistry (18) 18
research (18) 18
albumins - adverse effects (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Tam, YT and Gao, JM and Kwon, GS
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, ISSN 0002-7863, 07/2016, Volume 138, Issue 28, pp. 8674 - 8677
Poly(ethylene glycol)-block-poly(D,L-lactic acid) (PEG-b-PLA) micelles are nanocarriers for poorly water-soluble anticancer agents and have advanced paclitaxel... 
CREMOPHOR-FREE | STABILITY | HYDROLYTIC DEGRADATION | GENEXOL-PM | POLYMERIC MICELLES | FORMULATION | DERIVATIVES | CANCER | CHEMISTRY, MULTIDISCIPLINARY | BETA-LAPACHONE | PACLITAXEL
Journal Article
Journal Article
Molecular Pharmaceutics, ISSN 1543-8384, 08/2008, Volume 5, Issue 4, pp. 505 - 515
Journal Article
INTERNATIONAL JOURNAL OF NANOMEDICINE, ISSN 1176-9114, 2009, Volume 4, Issue 1, pp. 99 - 105
Breast cancer is the most common type of malignancy diagnosed in women. In the metastatic setting this disease is still uncurable. Taxanes represent an... 
paclitaxel | CREMOPHOR-FREE | GENE DELIVERY | HUMAN SERUM-ALBUMIN | breast cancer | CLINICAL-ASPECTS | NANOSCIENCE & NANOTECHNOLOGY | DELIVERY-SYSTEM | THERAPY | Abraxane | TAXOL | ENDOTHELIAL-CELLS | nanotechnology | PHARMACOLOGY & PHARMACY | NANOPARTICLE FORMULATION | PHASE-I
Journal Article
The Oncologist, ISSN 1083-7159, 06/2019, Volume 24, Issue 6, pp. 751 - e231
Lessons Learned Induction chemotherapy with Genexol‐PM and cisplatin demonstrated modest tumor response in locally advanced head and neck squamous cell... 
SURVIVAL | TRIAL | MULTICENTER | CREMOPHOR-FREE | ONCOLOGY | UNRESECTABLE HEAD | FLUOROURACIL | FORMULATION | DOCETAXEL | CONCURRENT CHEMORADIOTHERAPY | PACLITAXEL | Clinical Trial Results
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 01/2014, Volume 459, Issue 1-2, pp. 70 - 83
Journal Article